Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: Declarations. Conflict of interest: H.P.B.: No conflict of interest; S.V.: No conflict of interest; I.T.: No conflict of interest; G.K.: No conflict of interest; G.L.: Received speaker fee from SNIBE; N.R.J.: Received bone turnover marker assays free of charge for research from ROCHE, IDS and DiaSorin for research purposes; R.P.: No conflict of interest; M.M.: No conflict of interest; R.C.: Holds patents of 2 biomarkers of musculoskeletal diseases; M.Hiligsmann: Received research grants (paid to institution) from RADIUS HEALTH, and ANGELINI PHARMA, lecture fees from IBSA (paid to institution) and MYLAN PHARMACEUTICALS, and was grant advisor for PFIZER (paid to institution); M.Haarhaus: No conflict of interest; P.E.: Received research grants (paid to institution) from VIFOR CSL; H.S.J.: Received travel support from ABIOGEN PHARMA; M.Hermann: No conflict of interest; J-M.K.: No conflict of interest; P.C.: No conflict of interest; S.T.: No conflict of interest; N.A-D.: No conflict of interest; S.S.: No conflict of interest; M.S.A.: No conflict of interest; S.O.: No conflict of interest; M.C.P.Y.: No conflict of interest; R.M.: No conflict of interest; A.L.: No conflict of interest; M.M.C.d.S.R: No conflict of interest; L.Z.: No conflict of interest; N.B: No conflict of interest; E.M.: No conflict of interest; N.C.H: Received consultancy, lecture fees, honoraria, grant funding from ALLIANCE FOR BETTER BONE HEALTH, AMGEN, MSD, ELI LILLY, RADIUS HEALTH, SERVIER, SHIRE, UCB, CONSILIENT HEALTHCARE, KYOWA KIRIN, THERAMEX and INTERNIS PHARMA; R.P.R: No conflict of interest; M.F.: Received consultancy fees from ABIOGEN, AMGEN, VIFOR, OMEGA PHARMA; C.T.: No conflict of interest, the views expressed in this article are the personal views of the author and may not be understood or quoted as being made on behalf of or reflecting the position of the regulatory agencies by which the author is employed or affiliated; J.A.K.: No conflict of interest; R.R.: No conflict of interest; JY.R.: Stakeholder of SarQoL® whereas he never received any financial or non-financial compensation for this activity, received consultancy fees from IBSA, PROMEDIUS, VIATRIS, REJUVENATE BIOMED, CELLTRION, AGNOVOS, THERAMEX and VERSANIS BIO, CHUGAI, member of the Speakers Bureau for IBSA, RADIUS HEALTH, VIATRIS, AGNOVOS and TRB CHEMEDICA, received research grants (through Institutions) from IBSA, RADIUS HEALTH, ECHOLIGHT, VIATRIS, THERAMEX and TRB CHEMEDICA; K.M.: Received free of charge reagents from ROCHE, SNIBE and IDS for research purposes; E.C.: Consultant for IDS, DIASORIN, FUJIREBIO, NITTOBO and MENARINI. 2. Adv Emerg Nurs J. 2022 Apr-Jun 01;44(2):116-120. doi: 10.1097/TME.0000000000000410. Galeazzi Fracture-Dislocation. Ramponi DR(1). Author information: (1)School of Nursing, Education, and Human Studies, Robert Morris University, Moon Township, Pennsylvania. A Galeazzi fracture-dislocation is defined as a distal radius fracture with disruption of the distal radioulnar joint (DRUJ). The typical mechanism of injury is a forceful axial load with forearm torsion, which is often seen in a fall on the out stretched hand (FOOSH). The diagnosis is made with radiographs of the distal forearm and the wrist. The diagnosis can often be missed because ligament disruption of the distal radioulnar joint (DRUJ) can be overlooked. Treatment in children is usually nonsurgical with closed reduction and long arm cast. Adult treatment is usually open reduction and internal fixation. Complications can result in disability and include malunion, limited range of motion of the forearm, chronic pain, DRUJ instability, and osteoarthritis. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. DOI: 10.1097/TME.0000000000000410